Similar companies
Income Statement (USD)
Q3 '24 | QoQ | |
---|---|---|
Revenue | 2.8M | 827.7% |
Gross Profit | 1.5M | 297.1% |
Cost of Revenue | 1.2M | 14.3% |
Operating expense | 8.6M | 61.2% |
Net Income | -5.8M | 14.8% |
Balance Sheet (USD)
Q3 '24 | QoQ | |
---|---|---|
Total Assets | 11M | 171.4% |
Total Liabilities | 2.6M | 59.3% |
Total Equity | 8.5M | 468.3% |
Shares Outstanding | 8.6M | 106% |
Cash Flow (USD)
Q3 '24 | QoQ | |
---|---|---|
Cash from operations | -9.3M | 379% |
Cash from investing | -21,000 | 0% |
Cash from financing | 16M | 498% |
EPS
Financial Highlights for Geovax Labs in Q3 '24
Geovax Labs reported a revenue of 2.8M, which is a 827.7% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 1.5M, marking a 297.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.2M, a 14.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 8.6M, showing a 61.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -5.8M, showing a -14.8% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Geovax Labs faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies.